BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 31111504)

  • 1. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.
    Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M
    J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zhang Z; Bu X; Chen H; Wang Q; Sha W
    Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.
    Moon Y; Kim D; Sohn H; Lim W
    Clin Exp Metastasis; 2016 Jun; 33(5):487-96. PubMed ID: 27137188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells.
    Gong B; Yue Y; Wang R; Zhang Y; Jin Q; Zhou X
    Tumour Biol; 2017 Jun; 39(6):1010428317706217. PubMed ID: 28618953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
    Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TNF-α activates Wnt signaling pathway to promote the invasion of human colon cancer stem cells].
    Wei X; Li X; Kong F; Ma L; Sui Y; Chen D; Xu F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Nov; 34(11):982-988. PubMed ID: 30591106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown.
    Ye J; Wu D; Shen J; Wu P; Ni C; Chen J; Zhao J; Zhang T; Wang X; Huang J
    Mol Med Rep; 2012 Sep; 6(3):507-12. PubMed ID: 22684815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ; Kulkarni VM
    Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
    Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
    Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.
    Polireddy K; Dong R; McDonald PR; Wang T; Luke B; Chen P; Broward M; Roy A; Chen Q
    PLoS One; 2016; 11(10):e0164811. PubMed ID: 27764163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.
    Li W; Cho MY; Lee S; Jang M; Park J; Park R
    PLoS One; 2019; 14(8):e0220860. PubMed ID: 31393941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition.
    Zhou HM; Dong TT; Wang LL; Feng B; Zhao HC; Fan XK; Zheng MH
    World J Gastroenterol; 2012 Jun; 18(21):2640-8. PubMed ID: 22690072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-mediated delivery of functionally active miRNA-375-3p mimic regulate epithelial mesenchymal transition (EMT) of colon cancer cells.
    Rezaei R; Baghaei K; Amani D; Piccin A; Hashemi SM; Asadzadeh Aghdaei H; Zali MR
    Life Sci; 2021 Mar; 269():119035. PubMed ID: 33450254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.